Atazanavir--a once-daily HIV protease inhibitor that does not cause dyslipidemia in newly treated patients: results from two randomized clinical trials.

Pedro E Cahn; José M Gatell; Kathleen Squires; Lisa D Percival; Peter J Piliero; Ian A Sanne; Sarah Shelton; Adriano Lazzarin; Linda Odeshoo; Thomas D Kelleher

doi:10.1177/154510970400300304

Atazanavir--a once-daily HIV protease inhibitor that does not cause dyslipidemia in newly treated patients: results from two randomized clinical trials.

Identifier:nobleid.org/w1/20260515/1C748DF3

Type:Journal Article

0 views

Support unavailableClaim Your Authorship

View Original Paper Source

Embeddable Badge

[![NobleID](https://www.nobleid.org/api/badge/1C748DF3.svg?ark=w1%2F20260515%2F1C748DF3)](https://nobleid.org/work/w1/20260515/1C748DF3)

ARK Inflections

Metadata Policy

Metadata Formats

Bibliometric Analysis

Impact metrics, research fronts, co-authorship networks →

Authors & Claims

Paper Authors

Claim authorship of this work

Atazanavir--a once-daily HIV protease inhibitor that does not cause dyslipidemia in newly treated patients: results from two randomized clinical trials.

Identifier:nobleid.org/w1/20260515/1C748DF3

Type:Journal Article

0 views

Support unavailableClaim Your Authorship

View Original Paper Source

Embeddable Badge

[![NobleID](https://www.nobleid.org/api/badge/1C748DF3.svg?ark=w1%2F20260515%2F1C748DF3)](https://nobleid.org/work/w1/20260515/1C748DF3)

ARK Inflections

Metadata Policy

Metadata Formats

Bibliometric Analysis

Impact metrics, research fronts, co-authorship networks →

Authors & Claims

Paper Authors

Claim authorship of this work